Weed (BUDZ) Land & Improvements (2017 - 2026)
Weed's (BUDZ) quarterly Land & Improvements came in at $258319.0 in Q1 2026, little changed year-on-year from $258319.0 in Q1 2025, and little changed quarter-over-quarter from $258319.0 in Q4 2025.
Weed (BUDZ) Land & Improvements (2017 - 2026) Analysis & Trends
Weed's Land & Improvements history runs 10 years deep, the most recent figure standing at $258319.0 for Q1 2026.
- On a quarterly basis, Land & Improvements changed 0.0% year-over-year to $258319.0 in Q1 2026; TTM through Mar 2026 was $258319.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $258319.0, changed 0.0% from the prior year.
- Land & Improvements was little changed at $258319.0 in Q1 2026 per BUDZ's latest filing, from $258319.0 in the prior quarter.
- Across five years, Land & Improvements topped out at $383027.0 in Q1 2022 and bottomed at $258319.0 in Q3 2023.
- The 5-year median for Land & Improvements is $258319.0 (2023), against an average of $299110.6.
- Across the five-year window, Land & Improvements jumped 207.14% in 2022 and tumbled 30.57% in 2023, its largest moves.
- Year by year, Land & Improvements stood at $372069.0 in 2022, then tumbled by 30.57% to $258319.0 in 2023, then changed by 0.0% to $258319.0 in 2024, then changed by 0.0% to $258319.0 in 2025, then changed by 0.0% to $258319.0 in 2026.
- Per Business Quant, the three latest BUDZ Land & Improvements figures stand at $258319.0 (Q1 2026), $258319.0 (Q4 2025), and $258319.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 258,319.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 258,319.00 |
| Dec 31, 2025 | 258,319.00 |
| Sep 30, 2025 | 258,319.00 |
| Jun 30, 2025 | 258,319.00 |
| Mar 31, 2025 | 258,319.00 |
| Dec 31, 2024 | 258,319.00 |
| Sep 30, 2024 | 258,319.00 |
| Jun 30, 2024 | 258,319.00 |
| Mar 31, 2024 | 258,319.00 |
| Dec 31, 2023 | 258,319.00 |
| Sep 30, 2023 | 258,319.00 |
| Jun 30, 2023 | 372,069.00 |
| Mar 31, 2023 | 372,069.00 |
| Dec 31, 2022 | 372,069.00 |
| Sep 30, 2022 | 372,069.00 |
| Jun 30, 2022 | 372,069.00 |
| Mar 31, 2022 | 383,027.00 |
| Dec 31, 2021 | 383,027.00 |
| Sep 30, 2021 | 124,708.00 |
| Jun 30, 2021 | 124,708.00 |